Table 3.
Study (year) | Number of patients | Mean follow-up (months) | HR (95% CI) for stroke |
Takaya et al 56 (2006) | 154 | 38.2 | IPH: 5.2 (1.6 to 7.3) TRFC: 2.2 to 132.0 LRNC: 0.6 to 33.7 |
Singh et al 53 (2009) | 98 | 24.9 | IPH: 2.48 to 4.71 |
Sadat et al 57 (2010) | 61 | 16.9 | IPH: 1.27 to 26.77 TRFC: 7.39 (1.61 to 33.82) LRNC: 1.75 (0.55 to 5.54) |
Mono et al 54 (2012) | 65 | 18.9 | IPH: 0.03 (0.00 to 86.62) TRFC: 1.103 (0.11 to 10.70) LRNC: 7.2 (1.12 to 46.28) |
Kwee et al 55 (2013) | 126 | 12.0 | IPH: 3.5 (1.06 to 11.96) TRFC: 5.8 (1.91 to 17.32) LRNC: 3.2 (1.08 to 9.50) |
Hosseini et al 58 (2013) | 179 | 17.5 | IPH: 12 (4.8 to 30.1) |
ACS, asymptomatic carotid stenosis; IPH, intraplaque haemorrhage; LRNC, lipid-rich necrotic core; TRFC, thinning/rupture of the fibrous cap.